| 000 | 01059nam a2200337Ia 4500 | ||
|---|---|---|---|
| 003 | OSt | ||
| 005 | 20220912144006.0 | ||
| 006 | a|||||r|||| 00| 0 | ||
| 007 | ta | ||
| 008 | 220909b |||||||| |||| 00| 0 eng d | ||
| 020 | _a97801253942951 (hbk) | ||
| 024 | _a199404 | ||
| 037 | _b902, 09/03/2018, Capital Books Pvt.Ltd. | ||
| 037 | _cTextbook | ||
| 040 | _beng | ||
| 041 | _aeng | ||
| 082 | _aG116:(L:47257:6), Q4 | ||
| 100 | _aLattime Edmund C | ||
| 245 | 0 | _aGene theory of cancer: Translational approaches from preclinical studies to clinical implementation | |
| 250 | _a3 | ||
| 260 |
_aAmsterdam _bElsevier _c2013 |
||
| 300 |
_axv,537p. col. ill. _ccm |
||
| 500 | _aIndex 527-537p. | ||
| 650 | _a Immunotherapeutics | ||
| 650 | _a Oncolytic viruses | ||
| 650 | _a Viral and nonviral vector methodologies | ||
| 650 | _aBotany | ||
| 700 | _a Gerson Stanton L | ||
| 942 |
_hG116:(L:47257:6), Q4 _cTB _2CC |
||
| 999 |
_c268 _d268 |
||